|PRINT | CLOSE WINDOW|
Medtech’s annual conference in Rochester will focus on mapping the road to profitable growth for the bioscience and medical technology industry.
To be held Oct. 7 and 8, the event will feature Ken Adams, president, CEO and commissioner of Empire State Development Corp.
The bioscience and medical technology industry provides hundreds of thousands of direct and indirect jobs to New York State residents, Adams said in a statement. He is expected to highlight how new initiatives could further boost job creation in the state at the conference.
Conference panels include “Opportunities for Growing Bio/Med in NYS” and “Collaborations Between Academic Transfer Tech Offices and Private Industry”. These panels will teach companies how they can work with New York State and academic institutions to expand, develop innovative technology, and spur job creation in New York, Medtech officials said.
“Medtech 2013’s extensive agenda will help companies develop the relationships, tools, and programs to bring tomorrow’s medical solutions to the healthcare marketplace,” said MedTech President Jessica Crawford. “Our partners at Empire State Development and at colleges and universities throughout New York State are vital and expanding resources in driving profitable, sustainable growth in the bio/med industry.”
The Medtech 2013 conference will be open for registration online through Friday at www.medtech.org/medtech2013.
MedTech is a bioscience and medical technology industry association in New York State with nearly 100 members.
(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail email@example.com.